The above results together suggest a novel Wnt/β-catenin/TCF-1-KCNQ1OT1-miR-7-5p axis mediating ACVRL1 activation, which may contribute to mTKI resistance in CRC. Here, ACVRL1 is linked to colorectal carcinoma.